Neurocrine Biosciences Inc
$163.42
USD
Last updated on --.
24h volume825.00K
24h highest164.70 USD
24h lowest159.80 USD
24h Price movement+0.01%
NBIX recent prices
24 Hours
+0.01%+$0.01
30 days
-9.49%-$17.13
60 days
-1.10%-$1.820
90 days
+8.52%+$12.83
Key data
Previous close163.41 USD
Market cap16.25B USD
Volume825.00K
P/E ratio23.030000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)6.9400 USD
Net income (FY)705.50M USD
Revenue (FY)3.37B USD
Last report dateJul 31, 2026
About Neurocrine Biosciences Inc
HeadquartersSAN DIEGO
Employees (FY)2.50K
Revenue per employee (FY)1.35M USD
Net income per employee (FY)282.20K USD
Listed onNasdaq
NBIX conversion tables
 |  |
|---|---|
| 0.5 NBIX | 81.71 USD |
| 1 NBIX | 163.42 USD |
| 5 NBIX | 817.1 USD |
| 10 NBIX | 1,634.2 USD |
| |
|---|---|
| 0.5 USD | 0.0030596 NBIX |
| 1 USD | 0.0061192 NBIX |
| 5 USD | 0.030596 NBIX |
| 10 USD | 0.061192 NBIX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
NBIX is trading at $163.42, +0.01% over the last 24 hours. Track live moves on the price chart at the top of this page.
The NBIX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. NBIX is currently trading at $163.42, +0.01% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on NBIX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. NBIX's P/E ratio is currently 23.030000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from NBIX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against NBIX's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Neurocrine Biosciences Inc's market cap is currently 16.25B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume825.00K
24h highest164.70 USD
24h lowest159.80 USD
24h Price movement+0.01%
Start trade with NBIX Perpetual
Sign up to trade